Search

everythinglearnresearchcommunity

for

Search:↓

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

PRP may help short-term with ankle arthritis pain, but long-term effects are unclear.

Thyroid tests may not be needed for all vitiligo and alopecia areata patients unless thyroid disease symptoms appear.

Health care providers should address the emotional challenges of SLE patients with comprehensive care.

Early diagnosis using eye tests and lab markers can improve treatment for pediatric Sjögren's syndrome.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Strontium ranelate is no longer available for treatment.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Selenium's effectiveness in treating Hashimoto's thyroiditis is inconclusive.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

A woman with severe hair loss was successfully treated with the drug adalimumab.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

HPV does not cause aggressive cancer in RDEB patients.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Rabies vaccine might cause hair loss due to immune issues.